Regaal Resources Limited, India, made a strong stock market debut with shares listing at ₹141, a 38.24% premium over its IPO price of ₹102, reflecting strong investor demand and the company’s growth potential.
Regaal Resources Limited, India, delivered a stellar performance in its stock market debut on August 20, with shares listing at ₹141 on the NSE—representing a premium of 38.24% over its IPO price of ₹102. On the BSE, the stock opened slightly higher at ₹141.80, a 39% premium.
The company had raised ₹306 crore through its IPO, which attracted overwhelming participation across investor categories. The issue was subscribed nearly 160 times, highlighting robust demand. The Non-Institutional Investors’ segment stood out with a subscription of 356.72 times, while Qualified Institutional Buyers subscribed 190.96 times, and retail investors booked 57.75 times their quota.
Financial Utilization and Strategic Outlook
According to Regaal Resources, the IPO proceeds will primarily be directed toward repayment and prepayment of outstanding borrowings, totaling approximately ₹159 crore. The balance will be deployed for corporate purposes, which is expected to strengthen liquidity and support long-term expansion.
The company’s financials reflect solid momentum. For the fiscal year ended March 31, 2025, revenue surged 53%, while profit after tax jumped by 115%, underscoring its operational efficiency and rising profitability. Such financial performance contributed significantly to the market’s bullish outlook on the listing day.
Also Read: Regaal Resources IPO Allotment Status Today
About Regaal Resources
Established in 2012, Regaal Resources Limited is a leading maize specialty products manufacturer in India with a daily crushing capacity of 750 tonnes. Its product portfolio includes maize starch, modified starch, gluten, germ, and enriched fiber, alongside food-grade offerings like maize flour, icing sugar, custard powder, and baking powder.
The company’s growth trajectory, combined with India’s increasing demand for maize-based products across food, pharma, and industrial segments, positions it as a significant player in the starch industry. Analysts believe that the strong listing premium underscores investors’ confidence in both its business fundamentals and sectoral outlook.
READ MORE ON